Ying Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ying Tian has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Likun Gong
School of Chinese Materia Medica, Nanjing University of Chinese Medicine, China
3 shared publications - Jianhua Sun
Nanjing University of Chinese Medicine
2 shared publications - Carolyn Mary Ecelbarger
Department of Medicine, Georgetown University, Washington, DC 20057, USA
1 shared publication - Daisuke Aoki
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan
1 shared publication - Dandan Hu
Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China
1 shared publication Dengling Huang
Nanjing University of Chinese Medicine
1 shared publication
Latest Publications
- Open Access
Plant-Derived Saponin and Polysaccharide Vaccine Adjuvants: Structure–Activity Relationships and Immune-Enhancement Strategies
Plant-derived compounds, particularly saponins and polysaccharides, have attracted interest as vaccine adjuvants because of their diverse immunomodulatory activities. Increasing evidence suggests that the immunological activities of these compounds are closely associated with their structural characteristics, highlighting the importance of understanding how structural features influence their interactions with the immune system. Nevertheless, a systematic understanding of the relationships between structural features and immunological activity remains incomplete, limiting the rational development and optimization of plant-derived adjuvants. In addition, their broader development and translation are constrained by challenges such as poor stability, low bioavailability, insufficient immunostimulatory activity, and limited delivery efficiency. Against this background, this review focuses on the structure–activity relationships of plant-derived saponin and polysaccharide adjuvants, with particular emphasis on how key structural features influence the engagement of pattern recognition receptors (PRRs), antigen uptake and presentation, cytokine production, and subsequent humoral and cellular immune responses. Building on these structure–activity relationships, we further discuss current strategies for improving adjuvant performance, including structural modification and derivatization, delivery-system optimization, and combination strategies. Together, these insights provide a structure–activity framework for the rational design and development of more effective next-generation plant-derived saponin and polysaccharide adjuvants.
Open AccessPlant-Derived Saponin and Polysaccharide Vaccine Adjuvants: Structure–Activity Relationships and Immune-Enhancement Strategies
Plant-derived compounds, particularly saponins and polysaccharides, have attracted interest as vaccine adjuvants because of their diverse immunomodulatory activities. Increasing evidence suggests that the immunological activities of these compounds are closely associated with their structural characteristics, highlighting the importance of understanding how structural features influence their interactions with the immune system. Nevertheless, a systematic understanding of the relationships between structural features and immunological activity remains incomplete, limiting the rational development and optimization of plant-derived adjuvants. In addition, their broader development and translation are constrained by challenges such as poor stability, low bioavailability, insufficient immunostimulatory activity, and limited delivery efficiency. Against this background, this review focuses on the structure–activity relationships of plant-derived saponin and polysaccharide adjuvants, with particular emphasis on how key structural features influence the engagement of pattern recognition receptors (PRRs), antigen uptake and presentation, cytokine production, and subsequent humoral and cellular immune responses. Building on these structure–activity relationships, we further discuss current strategies for improving adjuvant performance, including structural modification and derivatization, delivery-system optimization, and combination strategies. Together, these insights provide a structure–activity framework for the rational design and development of more effective next-generation plant-derived saponin and polysaccharide adjuvants.
- Open Access
- 19 June 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1799877
From immunoinformatics insights to assay development: establishment of a peptide-based indirect elisa for cynomolgus tuberculosis detection
Tuberculosis (TB) is a severe zoonotic disease that represents a considerable threat to the health of captive non-human primates (NHPs). Conventional serological diagnostic methods often suffer from insufficient sensitivity and specificity, making them difficult to meet the requirements of large-scale screening in monkey colonies. In this study, we predicted and screened Mycobacterium tuberculosis antigenic epitopes using immunoinformatic approaches, and identified a novel antigenic peptide MP71 from the MPT64 protein. Based on the MP71-KLH conjugate, we further developed an indirect ELISA assay. In both the learning cohort ( n = 19) and independent validation cohort ( n = 21), the assay exhibited favorable and stable diagnostic performance: in the validation cohort, the AUC was >0.94 (95% CI: 0.8471 to 1.000), with a sensitivity of >92% and a specificity of 100%, together with favorable repeatability. The established ELISA represents a rapid, simple, and reliable serological tool that can be used for routine surveillance and large-scale preliminary screening of tuberculosis in monkeys.
- 19 June 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1799877
Open AccessFrom immunoinformatics insights to assay development: establishment of a peptide-based indirect elisa for cynomolgus tuberculosis detection
Tuberculosis (TB) is a severe zoonotic disease that represents a considerable threat to the health of captive non-human primates (NHPs). Conventional serological diagnostic methods often suffer from insufficient sensitivity and specificity, making them difficult to meet the requirements of large-scale screening in monkey colonies. In this study, we predicted and screened Mycobacterium tuberculosis antigenic epitopes using immunoinformatic approaches, and identified a novel antigenic peptide MP71 from the MPT64 protein. Based on the MP71-KLH conjugate, we further developed an indirect ELISA assay. In both the learning cohort ( n = 19) and independent validation cohort ( n = 21), the assay exhibited favorable and stable diagnostic performance: in the validation cohort, the AUC was >0.94 (95% CI: 0.8471 to 1.000), with a sensitivity of >92% and a specificity of 100%, together with favorable repeatability. The established ELISA represents a rapid, simple, and reliable serological tool that can be used for routine surveillance and large-scale preliminary screening of tuberculosis in monkeys.
- Open Access
- 29 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 349
AHR Deficiency Exacerbates Hepatic Cholesterol Accumulation via Inhibiting Bile Acid Synthesis in MAFLD Rats
Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a chronic liver disease characterized by abnormal lipid metabolism. The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor involved in regulating multiple physiological processes. Recent studies have demonstrated that AHR exerts a multifaceted regulatory role in liver diseases by integrating metabolic and immune signaling pathways; however, the specific role of AHR in MAFLD is not clear. In our work, a rat model of MAFLD was established by feeding wild-type (WT) and AHR knockout (AHR−/−) rats with a high-fat, high-fructose, and high-cholesterol diet (HFHFrHCD) for 10 weeks, and then the liver injury markers, lipid-related biochemical indices and liver histopathology were examined to elucidate the effect of AHR on MAFLD progression. We discovered that AHR deficiency can elevate plasma transaminase levels, increase hepatic triglyceride (TG) and total cholesterol (TC), and exacerbate insulin resistance (IR) under an overnutrition environment. Subsequently, liver transcriptome and RT-qPCR were performed to investigate the underlying mechanism, which revealed that the hepatic bile acid synthesis was inhibited because of lower Cytochrome P450 Family 7 Subfamily A Member 1 (CYP7A1) expression in the liver when AHR was knockout. Additionally, intestinal flora dysbiosis occurred in AHR−/− rats fed with HFHFrHCD, which might also contribute to the hepatic cholesterol accumulation. Taken together, our results suggested that AHR might play an important role in regulating cholesterol metabolism by inhibiting bile acid synthesis and breaking the steady state of the gut microbiota during the MAFLD progression.
- 29 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 349
Open AccessAHR Deficiency Exacerbates Hepatic Cholesterol Accumulation via Inhibiting Bile Acid Synthesis in MAFLD Rats
Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a chronic liver disease characterized by abnormal lipid metabolism. The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor involved in regulating multiple physiological processes. Recent studies have demonstrated that AHR exerts a multifaceted regulatory role in liver diseases by integrating metabolic and immune signaling pathways; however, the specific role of AHR in MAFLD is not clear. In our work, a rat model of MAFLD was established by feeding wild-type (WT) and AHR knockout (AHR−/−) rats with a high-fat, high-fructose, and high-cholesterol diet (HFHFrHCD) for 10 weeks, and then the liver injury markers, lipid-related biochemical indices and liver histopathology were examined to elucidate the effect of AHR on MAFLD progression. We discovered that AHR deficiency can elevate plasma transaminase levels, increase hepatic triglyceride (TG) and total cholesterol (TC), and exacerbate insulin resistance (IR) under an overnutrition environment. Subsequently, liver transcriptome and RT-qPCR were performed to investigate the underlying mechanism, which revealed that the hepatic bile acid synthesis was inhibited because of lower Cytochrome P450 Family 7 Subfamily A Member 1 (CYP7A1) expression in the liver when AHR was knockout. Additionally, intestinal flora dysbiosis occurred in AHR−/− rats fed with HFHFrHCD, which might also contribute to the hepatic cholesterol accumulation. Taken together, our results suggested that AHR might play an important role in regulating cholesterol metabolism by inhibiting bile acid synthesis and breaking the steady state of the gut microbiota during the MAFLD progression.
- Open Access
- 16 August 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (6) , e74
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
Hirano T, et al. J Gynecol Oncol. 2022 Aug;33(6):e74. https://doi.org/10.3802/jgo.2022.33.e74
- 16 August 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (6) , e74
Open AccessPrognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
Hirano T, et al. J Gynecol Oncol. 2022 Aug;33(6):e74. https://doi.org/10.3802/jgo.2022.33.e74
- 1 January 2002
- Published by Elsevier
- Vol. 139, 75-84
Chapter 6 Regulation of renal salt and water transporters during vasopressin escape
- 1 January 2002
- Published by Elsevier
- Vol. 139, 75-84
Chapter 6 Regulation of renal salt and water transporters during vasopressin escape